These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 2566492

  • 1. Microdialysis and striatal dopamine release: stereoselective actions of the enantiomers of N-0437.
    Timmerman W, Westerink BH, De Vries JB, Tepper PG, Horn AS.
    Eur J Pharmacol; 1989 Mar 14; 162(1):143-50. PubMed ID: 2566492
    [Abstract] [Full Text] [Related]

  • 2. The enantiomers of the dopamine agonist N-0437: in vivo and in vitro effects on the release of striatal dopamine.
    Timmerman W, Dubocovich ML, Westerink BH, De Vries JB, Tepper PG, Horn AS.
    Eur J Pharmacol; 1989 Jul 04; 166(1):1-11. PubMed ID: 2572424
    [Abstract] [Full Text] [Related]

  • 3. Characterization and pharmacological responsiveness of dopamine release recorded by microdialysis in the substantia nigra of conscious rats.
    Santiago M, Westerink BH.
    J Neurochem; 1991 Sep 04; 57(3):738-47. PubMed ID: 1677674
    [Abstract] [Full Text] [Related]

  • 4. Effects of D-2 agonists on the release of dopamine: localization of the mechanism of action.
    Timmerman W, De Vries JB, Westerink BH.
    Naunyn Schmiedebergs Arch Pharmacol; 1990 Dec 04; 342(6):650-4. PubMed ID: 1982893
    [Abstract] [Full Text] [Related]

  • 5. Enantiomers of monohydroxy-2-aminotetralin derivatives and their activity at dopamine autoreceptors as studied by brain dialysis.
    Timmerman W, Tepper PG, Dijkstra D, Stoelwinder H, Grol CJ, Westerink BH, Horn AS.
    Eur J Pharmacol; 1991 Jun 25; 199(2):145-51. PubMed ID: 1683287
    [Abstract] [Full Text] [Related]

  • 6. Role of adenylate cyclase in the modulation of the release of dopamine: a microdialysis study in the striatum of the rat.
    Santiago M, Westerink BH.
    J Neurochem; 1990 Jul 25; 55(1):169-74. PubMed ID: 1693944
    [Abstract] [Full Text] [Related]

  • 7. The effects of the enantiomers of the dopamine agonist N-0437 on food consumption and yawning behaviour in rats.
    Timmerman W, Rusk IN, Tepper P, Horn AS, Cooper SJ.
    Eur J Pharmacol; 1989 Dec 12; 174(1):107-14. PubMed ID: 2575532
    [Abstract] [Full Text] [Related]

  • 8. The regulation of dopamine release from nigrostriatal neurons in conscious rats: the role of somatodendritic autoreceptors.
    Santiago M, Westerink BH.
    Eur J Pharmacol; 1991 Oct 29; 204(1):79-85. PubMed ID: 1687125
    [Abstract] [Full Text] [Related]

  • 9. The potential antipsychotic activity of the partial dopamine receptor agonist (+)N-0437.
    Timmerman W, Tepper PG, Bohus BG, Horn AS.
    Eur J Pharmacol; 1990 Jun 08; 181(3):253-60. PubMed ID: 1974516
    [Abstract] [Full Text] [Related]

  • 10. In vivo evidence for a concordant response of terminal and dendritic dopamine release during intranigral infusion of drugs.
    Westerink BH, Santiago M, De Vries JB.
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Dec 08; 346(6):637-43. PubMed ID: 1362452
    [Abstract] [Full Text] [Related]

  • 11. The effects of kainic acid and 6-hydroxydopamine lesions, metal ions and GTP on in vitro binding of the D-2 dopamine agonist, [3H]N-0437, to striatal membranes.
    Van der Weide J, De Vries JB, Tepper PG, Horn AS.
    Eur J Pharmacol; 1987 Nov 03; 143(1):101-7. PubMed ID: 3121365
    [Abstract] [Full Text] [Related]

  • 12. Chronic cocaine treatment impairs the regulation of synaptosomal 3H-DA release by D2 autoreceptors.
    Yi SJ, Johnson KM.
    Pharmacol Biochem Behav; 1990 Jul 03; 36(3):457-61. PubMed ID: 1974064
    [Abstract] [Full Text] [Related]

  • 13. N-0437: a selective D-2 dopamine receptor agonist in in vitro and in vivo models.
    Van der Weide J, De Vries JB, Tepper PG, Krause DN, Dubocovich ML, Horn AS.
    Eur J Pharmacol; 1988 Mar 01; 147(2):249-58. PubMed ID: 3130270
    [Abstract] [Full Text] [Related]

  • 14. The enantiomers of the D-2 dopamine receptor agonist N-0437 discriminate between pre- and postsynaptic dopamine receptors.
    Van der Weide J, Tendijck ME, Tepper PG, De Vries JB, Dubocovich ML, Horn AS.
    Eur J Pharmacol; 1988 Feb 09; 146(2-3):319-26. PubMed ID: 2836210
    [Abstract] [Full Text] [Related]

  • 15. Pharmacological profiles of three new, potent and selective dopamine receptor agonists: N-0434, N-0437 and N-0734.
    Van der Weide J, De Vries JB, Tepper PG, Horn AS.
    Eur J Pharmacol; 1986 Jun 17; 125(2):273-82. PubMed ID: 3743637
    [Abstract] [Full Text] [Related]

  • 16. Effect of quinine on autoreceptor-regulated dopamine release in the rat striatum.
    Tanaka T, Vincent SR, Nomikos GG, Fibiger HC.
    J Neurochem; 1992 Nov 17; 59(5):1640-5. PubMed ID: 1357098
    [Abstract] [Full Text] [Related]

  • 17. Pharmacological profile of N,N dipropyl-8-hydroxy-3-chromanamine, an oxygen isostere of the dopamine agonist N,N dipropyl-5-hydroxy-2-aminotetralin with enhanced presynaptic selectivity.
    Vermue NA, Kaptein B, Tepper PG, de Vries JB, Horn AS.
    Arch Int Pharmacodyn Ther; 1988 Nov 17; 293():37-56. PubMed ID: 3421784
    [Abstract] [Full Text] [Related]

  • 18. Importance of the calcium content infused during microdialysis for the effects induced by D2 agonists on the release of dopamine in the striatum of the rat.
    Timmerman W, Westerink BH.
    Neurosci Lett; 1991 Sep 30; 131(1):93-6. PubMed ID: 1686479
    [Abstract] [Full Text] [Related]

  • 19. Transdermal administration of the dopamine agonist N-0437 and seven ester prodrugs: comparison with oral administration in the 6-OHDA turning model.
    den Daas I, Tepper PG, Rollema H, Horn AS.
    Naunyn Schmiedebergs Arch Pharmacol; 1990 Dec 30; 342(6):655-9. PubMed ID: 1982894
    [Abstract] [Full Text] [Related]

  • 20. Stereoisomers of the atypical neuroleptic carbidine modulate striatal dopamine release in awake rats.
    Guinetdinov RR, Bogdanov MB, Pogorelov VM, Kudrin VS, Rayevsky KS.
    Neuropharmacology; 1991 Nov 30; 30(11):1251-4. PubMed ID: 1685561
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.